The zebrafish (Danio rerio) is a small tropical fish that, in recent years, has proven to be a highly relevant animal model in biomedical research, offering a unique combination of advantages, including its ability to reproduce key aspects of human biology and its ease of genetic manipulation.
Many scientists consider it to be particularly important in developmental biology studies and neurodegenerative diseases, especially Parkinson’s disease, and the development of new drugs to treat this condition.
One of the most significant discoveries was documented in an article published in Frontiers in Genetics, where aminergic structures and the mechanisms of action of the neurotoxin MPTP were presented, showing compatibility with mammals, suggesting that these findings could be applied to human studies.
Another aspect that makes this fish an ideal model for research is its ability to be genetically manipulated, allowing scientists to explore the effects of specific mutations related to Parkinson’s disease in great detail.
In a recent systematic study, the use of neurotoxins to induce parkinsonism in zebrafish embryos and larvae was documented, providing valuable insights into which chemical models are most suitable for studying this disease.
Moreover, comparative research has demonstrated that the zebrafish is highly sensitive to the neurotoxic agents involved in Parkinson’s disease, with results consistent with those obtained in mammalian models, further validating its use in neurodegeneration studies.
In conclusion, the use of zebrafish in Parkinson’s disease research has not only led to a better understanding of the disease’s mechanisms but has also opened new avenues for the discovery of effective therapies. With its ability to perform genetic and pharmacological testing quickly and efficiently, the zebrafish is becoming an indispensable model in the fight against Parkinson’s disease and other movement disorders.
Related
